Pharmaceuticals
Dutch company Micreos launches first non-antibiotic treatment for MRSA, Staphefekt
08 Nov 2014
Micreos says Endolysin Staphefekt was the first such treatment available for human use on intact skin that had multiple benefits as compared to antibiotics
Botox maker Allergan in talks with new suitor
07 Nov 2014
Allergan did not name the proposed new suitor, which some media reports speculated might be Actavis Inc
Perrigo Co to buy Belgian pharmaceutical firm Omega Pharma for $4.5 bn
06 Nov 2014
US private-label over the counter medicines maker Perrigo today struck a deal to buy Belgian pharmaceutical company Omega in a bid to expand in Europe
AstraZeneca strikes three oncology deals
04 Nov 2014
British pharmaceutical company AstraZeneca today struck three deals to strengthen its oncology business
Wockhardt Q2 net plunges 97% on US export ban
04 Nov 2014
Cipla wants Novartis’s patents on respiratory drug revoked
30 Oct 2014
Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease
Merck oncology drug wins ‘breakthrough’ classification by US regulators
28 Oct 2014
Keytruda, Merck & Co's flagship new drug, forms part of a new generation of oncology treatments that use the body’s own immune system to attack and destroy tumours
CSL to acquire Novartis’ influenza vaccine unit
27 Oct 2014
Pfizer's $11-bn share repurchase ends chances of renewed bid for AstraZeneca
25 Oct 2014
US drugmaker Pfizer’s board yesterday authorised a new $11-billion share repurchase plan, which analysts say puts an end to speculations that it would renew its bid for British rival AstraZeneca
AbbVie calls off $55-bn acquisition of Shire over US tax rules
22 Oct 2014
AbbVie said the new US tax rules would keep it from gaining access to its overseas cash without having to pay hefty US taxes
Pfizer’s anti-smoking drug Chantix to carry black-box waning till availability of study data
17 Oct 2014
AbbVie to reconsider $55-bn Shire deal
15 Oct 2014
AbbVie, the maker of top-selling arthritis drug Humira, plans to buy Shire to lower its US tax burden by moving its tax base to Ireland and to diversify its product line-up
Suven Life secures product patent in S Korea, US
13 Oct 2014
Valeant Pharmaceuticals plans to raise bid for Allergan
08 Oct 2014
Valeant is taking its takeover offer close to a December shareholder meeting where some of Allergan’s directors face removal
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
